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The ability of mice to form antibodies against the linear, random terpolymer, 
poly-(Glu~3Lys36Phe  11)  (GLib) has been shown to be  under the control of two 
major histocompatibility complex (MHC)l-linked immune response (Ir)  genes 
termed a and fl (1, 2). The sites of expression of these Ir genes have not yet been 
elucidated. Recently, Munro and Taussig have studied another two-gene model, 
namely that for poly-(Tyr,Glu)-poly-D,L-Ala--poly  Lys [(T,G)-A--L],  and have 
postulated that in their system one gene is expressed in the thymus-derived (T) 
lymphocyte and the other in the bone marrow-derived (B) lymphocyte (3). To 
assess this possibility in the GL¢ system, we have examined the T-lymphocyte 
proliferative response to  GL¢  in  a  variety of mouse strains  using  a  newly 
developed assay system which employs nylon wool column-purified peritoneal 
exudate  lymphocytes (4). Our  results  demonstrate that  strains  bearing re- 
sponder alleles at only the a- or the B-locus are nonresponders as assessed by T- 
lymphocyte proliferation. Yet, similar to the requirement for antibody forma- 
tion, strains possessing responder alleles at both loci are responders. The a- and 
fl-genes can complement each other in both the trans position (F1 hybrids) or the 
cis  position (recombinant strains) to give responder phenotypes. The comple- 
mentation in cis  appears  to  be  stronger than  that  in trans.  These findings 
mitigate against the possibility that either of the Ir genes necessary for the GL¢ 
response is expressed solely in B lymphocytes because it would be anticipated 
that mice with a defect limited to the B lymphocyte would express a normal T- 
lymphocyte proliferative response. 
Materials and Methods 
Animals.  Mice  were  purchased  from  The  Jackson  Laboratory,  Bar  Harbor,  Maine  or  the 
Rodent and Rabbit Production Section of the Division of Research Services, National Institutes of 
Health. Several strains were raised either in the animal facilities of Harvard Medical School or 
those of the Laboratory of Immunology,  National Institute of Allergy and Infectious Diseases, 
* This work was supported in part by grant AI-09920 from the National Institutes of Health, U. 
S.  Public Health Service. 
1  Abbreviations used in this paper: MHC, major histocompatibility complexes; PETLES, perito- 
neal exudates, T-lymphocyte-enriched cells; PPD, purified protein derivitive. 
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National  Institutes  of  Health.  All  mice  were  between  6  and  24  wk  of  age  at  the  start  of 
immunization. 
Antigens.  The random linear synthesis terpolymer poly-(Glu53Lys~6PheH), sample No.  GF 6- 
23-8  (GLdP),  was  synthesized from the N-carboxyanhydrides  and donated by  Dr.  Elkan  Blout, 
Department of Biological Chemistry,  Harvard Medical School,  Boston, Mass.  The polymer was 
dissolved in 1 N  NaOH, neutralized to pH 7.2 with 1 N HC1,  and stored at -20°C. Purified protein 
derivative of tuberculin (PPD) was purchased from Connaught Medical Research Labs.,  Willow- 
dale,  Ontario,  as a  2  mg/ml solution, and stored at  -20°C.  Before addition to the cultures both 
antigens were diluted to appropriate concentrations with culture medium. 
Immunization.  Mice  were  immunized  with  20  /~g  of GLcb  in  complete  Fruend's  adjuvant 
containing 1 mg/ml of Mycobacterium tuberculosis, strain H37 Ra (Difco Laboratories,  Detroit, 
Mich.). The emulsion was distributed equally between the two hind footpads. The animals were 
sacrificed 3 to 6 wk later. 
Cell Cultures.  The preparation of peritoneal exudate, T-lymphocyte-enriched cells (PETLES), 
and  their  in  vitro  culture  with  antigen  has  been  described  in  detail  elsewhere  (4).  Briefly, 
thioglycollate-induced peritoneal exudate cells were passed over nylon wool columns to obtain the 
PETLES. This population contained an average of only 2% B lymphocytes. The cells were cultured 
at 1 x  10  ~ per well in microtiter plates containing 0.2 ml of EHAA medium supplemented with 10% 
heat-inactivated fetal calf serum (Grand Island Biological Co., Grand Island, N. Y.). Control wells 
received no antigen, and antigen-stimulated wells received either 100 ~g/ml of GL¢ or 20-40 ~g/ 
ml of PPD.  The cells were cultured for 5 days,  and proliferation was assessed by measuring the 
incorporation of a  1 ~Ci pulse of tritiated-methylthymidine (Amersham/Searle Corp., Arlington 
Heights, Ill.: Sp Act 5Ci/mmol). The data are expressed as counts per minute -+ the standard error 
of the mean (SEM) for triplicate determinations. Strains were designated as responders to GL¢ if 
there was a statistically significant difference between antigen-stimulated and control cultures as 
measured by a  Student's t test (P -< 0.05). 
Results 
T-Lymphocyte Proliferative Response  to GLdP.  GLdP  proved to be a  potent 
stimulator of T-lymphocyte proliferation in the mouse.  When PETLES were 
prepared  from  B10.D2  mice  3  wk  after  immunization with  20  /~g  of GLcP 
emulsified in complete Freund's adjuvant, challenge with the antigen in vitro 
resulted in a substantial incorporation of tritiated thymidine by these cells. The 
mean  incorporation,  expressed  as  the  difference between antigen-stimulated 
and control cultures, hcpm, for the three such experiments shown in Table I was 
110,000 cpm. The response to GLcP in this strain was always equal to or greater 
than the response  of the same B10.D2  cells to PPD.  The GLcP response  was 
maximum at 3 wk after immunization and slowly declined thereafter (Table I, 
experiments 4 and 5). 
The  T-Lymphocyte  Proliferative  Response  to  GLdP is  under  Genetic  Con- 
trol.  Examination of the response to GL¢ by PETLES from a variety of inbred 
mouse strains revealed a division of  the strains into responder and nonresponder 
categories.  Strains  were  assigned a  responder status  if the  incorporation of 
tritiated thymidine in the presence of GLcP was significantly greater (P <  0.05) 
than the incorporation in the absence of GL~P. Responder ~trains were further 
divided into marginal (_+), weak (+), or strong responders (+ +) depending on 
the magnitude of the proliferative response. 
Responsiveness  appeared  to  be  associated  with H-2  haplotype  (Table  II). 
Strains having the d, j, q,  or r  haplotype were responders to GLcP,  2 whereas 
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TABLE  I 
T-Lymphocyte Proliferative Response to Poly-(Glu'~3LysS~Phe H) 
899 
Exp.  no. 
Weeks 
aRer im- 
munized 
Proliferative response (cpm -+ SEM) to: 
Medium  GLcP  PPD 
1  3  1,900  ±  200  115,400  ±  17,800  108,900  ±  2,400 
2  3  5,000 ±  3,400  92,400  ±  2,500  45,600  ±  3,900 
3  3  1,700 ±  300  131,600  ±  3,100  67,500  ±  1,200 
4  4  4,100 ±  500  44,700 ±  8,900  - 
5  6  740  ±  320  29,600  ±  3,700  - 
1 x 105 PETLES  from B10.D2 mice, which had previously been immunized with GLdP emulsified in 
C FA, were cultured with either 100 t~g/ml of  GLdp, 20 ~g/ml of  PPD, or  medium alone. Stimulation 
was assessed 5 days later by measuring the incorporation  of a pulse of  tritiated thymidine. The 
data are expressed as mean counts per minute _+ SEM  for triplicate  determinations. 
TABLE II 
Strain Distribution of the T-Lymphocyte Proliferative Response to Poly-(Glu'~3Lys36Phe 1~) 
H-2  Proliferative response (cpm  -+ SEM) to:*  Respon- 
Strain  haplo-  siveness 
type  Medium  GLcP  PPD 
A/J  a  1,500 _+ 500  2,000  --  1,000  38,000  ±  1,400  - 
B10.A/SgSn  a  400 _+ 100  450 ±  60  87,700  -+ 6,500  - 
C57BL/10Sn  b  1,000  _+ 100  1,200  ±  200  51,500  ±  1,500  - 
C57BL/6N  b  2,400 _+ 800  4,900 •  1,700  17,900 -+ 2,800  - 
BALB/cAnN  d  2,100  __ 300  28,700  ±  1,600  145,100  _+ 3,100  ++ 
B10.D2/nSn  d  1,900 -+ 200  115,400  _+ 17,800  108,900  -+ 2,400  ++ 
I/StN  j  37,600 _  1,900  131,100  ~- 2,600  87,400  -+ 15,600  ++ 
C3H/HeN  k  900 +- 250  300 +_ 70  29,200  -+ 1,900  - 
B10.BR/SgSn  k  2,900  _+ 600  5,500  ±  1,500  81,600  --  2,500  - 
DBA/1J  q  1,600  _+ 50  64,600  ±  4,500  12,700 ±  500  ++ 
SWR/J  q  2,500 _+ 900  37,600  ±  5,200  17,400  -+ 400  + + 
B10.RIII  r  3,100  _+ 800  50,400  _* 4,000  5,100 +- 1,500  + + 
SJL/J  s  1,700  _+ 700  800 ±  200  217,000  -+ 20,700  - 
B10.S  s  2,000 +_ 500  4,200 +- 1,500  38,000 -  2,900  - 
B10.SM  v  1,800 +- 300  2,500 +_ 500  11,300 -+ 1,900  - 
* Culture conditions were the same as described in Table I. 
Strains were assigned a nonresponder  status (-) if  the incorporation of  tritiated  thymidine in 
the presence of GL¢  was not significantly different (Student's t  test)  from the incorporation in 
the absence of  GLcP. Responder strains were divided into marginal (_),  weak (+), or  strong (+ +) 
responders depending on the magnitude of the proliferative response. 
strains  having  the  a, b, k, s,  or v  haplotype  were  nonresponders.  Nonresponder 
strains  had  specific defects  in  responsiveness,  since  in  every  case  the  PETLES 
from  such  strains  responded  well to PPD.  The  proliferative  response  of congenic 
resistant  strains  located  the  genes  controlling  responsiveness  to the  MHC.  For 
example,  the  B10.D2/nSn  strain,  which  contains  H-2  genes  of the  same  haplo- 
type  as the  responder  BALB/c  strain  associated  with  the  non-H-2  genes  of the 
nonresponder  C57BL/10  strain,  was  a  responder  to  GLcP.  In all cases  the  desig- 
nation  of a  strain  as a  responder  or nonresponder  for T-lymphocyte  proliferation 
to  GLcP  correlated  exactly  with  the  designation  previously  assigned  those 900 
Strain 
T-LYMPHOCYTE  RESPONSE  TO  POLY-(GLU53LYS36pHE H) 
TABLE  HI 
Complementation of the 1-1-2  a and H-2  ~ Haplotypes 
MHC alleles  Proliferative response (epm ±  SEM) to:* 
K,I-A,I-B,I-C,S,D  Medium  GL~P  PPD 
Respon- 
sivenesst 
B10.D2/nSn 
C57BL/10Sn 
B10.A/SgSn 
(B10 x  B10.A)F~ 
B10.A(5R)/SgSn 
C57BL/6N 
A/J 
dddddd 
bbbbbb 
hhkddd 
bbbbbb 
kkkddd 
bbbddd 
bbbbbb 
kkkddd 
bbbbbb 
(B6  x  A)F~  k  k  k  d  d  d 
(B10.A  x  A)F~  k  k  k  d  d  d 
B10.A(2R)/SgSn  k  k  k  d  d  b 
B10.A(4R)/SgSn  k  k  b  b  b  b 
B10.A(18R)  b  b  b  b  b  d 
1,900  ±  200  115,400  ±  17,800  108,900  ± 
1,000  ±  100  1,400  ±  200  109,900  ± 
2,300 ±  500  900 ±  200  123,200 ± 
2,300 ±  200  130,000 ±  2,700  140,500 ± 
1,200 ±  300  79,900 ±  4,500  50,600 ± 
2,400  -+ 800  4,900  ±  1,700  17,900  ± 
1,500 ±  500  2,000 ±  1,000  38,000 -+ 
3,400 ±  1,200  49,300 ±  7,800  30,200 ± 
8,400± 3,100  5,500 ±  1,600  113,400 ± 
400 ±  120  550 ±  150  102,700 ± 
2,200 ±  500  2,500 ±  400  69,400 ± 
6,200± 400  7,400 ±  1,300  121,200± 
2,400 
15,200 
11,300 
6,600 
4,200 
2,800 
1,400 
7,800 
11,700 
11,600 
2,400 
5,600 
++ 
++ 
++ 
++ 
* Culture conditions were the same as described in Table I. 
t  See Table II. 
TABLE IV 
Complementation of the H-2 k and H-2" Haplotypes 
MHC alleles 
Strain  K J-A,I-B  J-C  ,S,D 
Proliferative response (cpm ±  SEM) to:* 
Medium  GL¢  PPD 
Responsiveness* 
C57BL/10Sn  b  b  b  b  b  b  1,000 -+  100  1,400 ±  200  109,900 ±  15,200 
C3H/HeN  k  k  k  k  k  k  900 ±  250  300 ±  70  29,200 ±  1,900 
B10.BR/SgSn  k  k  k  k  k  k  2,900 ±  600  5,500 ±  1,500  81,600 ±  2,500 
SJL/J  s  s  s  s  s  s  1,700 ±  700  800 -+ 200  217,000 ±  20,700 
B10.S  s  s  s  s  s  s  5,400 ±  1,100  3,800 ±  1,100  29,500 ±  2,800 
(B10.BR ×  B10.S)F~  k  k  k  k  k  k  700 ±  150  4,400 ±  1,100  118,800 ±  12,100 
8  8  $  8  8  8 
(C3Hx  SJL)FI  sk  sk  :  :  :ks  28,900± 4,300  52,700± 5,100  143,100 ±  5,200 
B10.HTT  s  s  s  k  k  d  860 ±  150  50,100 ±  6,500  33,900 ±  4,800 
B10.S(9R)  s  s  8  d  d  d  5,700 ±  1,100  66,600 ±  5,100  41,100 ±  2,100 
B10.S(7R)  s  8  s  s  s  d  8,200 ±  1,700  8,300 ±  2,100  77,800 ±  4,100 
+ 
+ 
++ 
++ 
* Culture conditions were the same as described in Table I. 
t  See Table II, 
strains on the basis of serum antigen-binding tests for antibody formation to 
GL(P (1, 2). 
Evidence for  Two Ir  Genes Controlling  the  T-Lymphocyte Proliferative Re- 
sponse to GL4P.  The antibody response to GLq) has been shown to be under the 
control of two dominant MHC-linked Ir genes, a  and ~ (1, 2). This was demon- 
strated by showing that different types of nonresponder strains could comple- 
ment each other to give a responder phenotype if genetic material from each of 
them was  brought together in  either the  trans  position,  by formation of F1 
hybrids, or the cis  position, by recombination events. A similar approach was 
used for the study of the T-lymphocyte response to GLq). 
The results in Table III illustrate again that strains of either the H-2 a or H-2 b 
haplotypes are  nonresponders to GLq).  However,  a  combination of these two SCHWARTZ,  DORF,  BENACERRAF,  AND  PAUL 
TABLE  V 
Complementation  of the H-2  b and H-2" Haplotypes 
H-2 haplo-  Proliferative  response (cpm -  SEM) to:*  Respon- 
Strain 
type  Medium  GL@  PPD  siveness~ 
901 
C57BL/6N  b  2,400  +--  800  4,900  -+  1,700  17,900 -+ 2,800  - 
C57BL/10Sn  b  1,000  +-  100  1,260  -  200  51,500 -+  1,500  - 
SJL/J  s  1,700  -+  700  800  -+  200  217,000  -+  20,700  - 
B10.S  s  5,400  +-  1,100  3,800  -+  1,100  29,500 -+ 2,800  - 
(B6  x  SJL)F,  b/s  2,200  -+  300  7,200  -+  1,000  44,800  +--  18,300  + 
(B10  x  B10.S)F,  b/s  5,300  -+  1,400  8,200  -+  100  41,600  +-  300  -+ 
* Culture conditions were the same as described in Table I. 
See Table II. 
MHC genomes in either the trans  position,  as seen with the (B10  ×  B10.A)F1 
hybrid,  or  the  cis  position,  as  seen  with  the  B10.A(5R)  recombinant  strain, 
resulted in  mice that  responded to GL~.  The  magnitude  of the response was 
similar to that of the B10.D2 responder strain.  Other F1 hybrids, such as the (B6 
×  A)F~ were also responders to GL~, but the (B10.A  ×  A)F1 hybrid, in which 
complementation of only the non-H-2  genes is achieved,  was a  nonresponder. 
Recombinants  between the H-2 a  and H-2  ~ haplotypes  other  than  B10.A(5R), 
such as B10.A(2R), B10.A(4R), and B10.A(18R), were all nonresponders.  These 
recombinants  localize  the H-2  a  haplotype gene (a)  to the region  of the  MHC 
between I-B  and D, and the H-2  b haplotype gene (~) to the left of I-C. 
Mice of the H-2 k and H-2" haplotypes are both nonresponders to GL@. Table 
IV demonstrates that these haplotypes can also complement one another. In this 
case, however, the cis complementation is much more successful than the trans 
complementation.  Thus, recombinants,  such as B10.HTT, showed strong prolif- 
erative responses to GL~, whereas the F1 hybrids, such as (B10.BR x  B10.S)F~ 
and (C3H ×  SJL)F~, showed only weak, but significant, proliferative responses. 
The  B10.S(9R) recombinant  demonstrated  that  the H-2 a and H-2 k  haplotypes 
share  a  similar  Ir  gene  (a)  capable  of complementing  a  gene  of the  H-2" 
haplotype.  The lack of response by the  B10.S(7R) recombinant  located the  a- 
gene of the H-2 a and H-2 k haplotypes to the region of the MHC between I-B and 
D. 
Inasmuch as the H-2 a and H-2 k a-genes can be complemented by genes of the 
H-2 b and H-2" haplotypes, respectively, the implication is that the H-2  b and H-2" 
haplotypes possess responder alleles at the E-locus and nonresponder alleles at 
the a-locus.  To further examine this point, we studied the response of (H-2 b  × 
H-2")F1 hybrids (Table V). In agreement with the serological data (2), PETLES 
from both the (B6  ×  SJL)F1 and the (B10  ×  B10.S)F~ strains  gave weak, but 
statistically significant, responses to GL~, although the response of the former 
appeared to be somewhat greater than the response of the latter. Because the H- 
2 k and H-2" trans complementations were also weak, it is possible that all trans 
complementations  involving H-2"  genes are  inefficient,  and thus  (H-2 b  ×  H- 
2")F~  strains  fail  to  demonstrate  the  degree  of complementation  possible be- 
tween genes of these haplotypes.  Alternatively,  it is possible that the meager 902  T-LYMPHOCYTE  RESPONSE  TO  POLY-(GLU53LYS36pHE 11) 
response of the (B10 ×  B10.S)F~  strain, although statistically significant, is not 
biologically meaningful,  and  the  partial  complementation  seen in  the  (B6  × 
SJL)F~ strain  represents some contribution  of non-H-2  genes of the SJL.  The 
data, therefore, do not allow us to reach a definitive conclusion as to whether H- 
2 b and H-2"  haplotypes, both presumably of an  a-,B  + phenotype, can comple- 
ment each other. This point is, of course, important in the attempt to determine 
whether the B-alleles of H-2 b and H-2" are the same or, indeed, whether a more 
complex system involving three polymorphic H-2-1inked Ir-GL¢  may be operat- 
ing. 
Discussion 
Our earlier studies of the genetic control of T-lymphocyte proliferation in the 
mouse using seven distinct antigens,  responsiveness to which is controlled by 
MHC-linked Ir genes, indicated that the responder-nonresponder  pattern was 
identical  to  that  described for antibody-forming  capacity  2.  Similarly,  studies 
with guinea pigs have shown a concordance in responder status, as determined 
by both antibody responses and T-lymphocyte proliferation (5). Since all known 
antibody responses controlled by MHC-linked Ir  genes are  dependent  on the 
participation of helper T lymphocytes, the simplest hypothesis to relate the two 
sets of observations would be to propose that Ir genes exert their effects in the 
process required for stimulation of the T lymphocyte. However, with the recent 
finding that the response to several antigens appears to be under the control of 
two independent,  MHC-linked Ir genes (1-3), the situation becomes more com- 
plex. The goal of the present work was to examine the T-lymphocyte prolifera- 
tive response in one of these systems (GL¢) to determine whether only one or 
both of these Ir  genes was required  to obtain  an  immune  response at the T- 
lymphocyte level. 
The results were unequivocal.  Mice of the H-2 a and H-2 k haplotypes, which 
possess a responder allele at the a, but not the B, Ir-GLcb locus, and mice of the 
H-2 b and H-2" haplotypes, which possess a responder allele at the B, but not the 
a, Ir-GL~P locus, were all nonresponders in the proliferation assay. That, in fact, 
there  were two distinct  gene defects accounting for nonresponsiveness in this 
system  was  shown  by  the  analysis  of F1  hybrid  and  recombinant  strains. 
PETLES from (H-2 b  × H-2a)FI hybrids and from B10.A (5R) recombinant mice 
were as responsive to GLcP as were those from B10.D2 responders.  Similarly, 
B10.HTT and B10.S(9R) recombinant mice, which were derived from the H-2" 
and H-2 ~ or H-2 k nonresponder haplotypes, were excellent responders. PETLES 
from (H-2"  × H-2 k) F~ hybrids also responded, although their response was much 
weaker than  that  of the other types of combinations.  These complementation 
results  thus  demonstrate  the  operation  of two Ir  genes  (a  and  B)  in  the  T- 
lymphocyte response to GLib, and show that, in some cases, the cis complemen- 
tation  appears  to be more successful than  the  trans  complementation.  These 
results are completely analogous to those observed when antibody responses are 
examined  (1,  2,  6).  In  the  present  studies  the  possibility  that  the  weaker 
complementation  in  the  trans  position might  be explained  by a  gene  dosage 
effect was not examined.  However, we consider this possibility unlikely since 
serological  analysis of the  GLib response  of the  (B10.HTT  ×  A.Ca)F1  hybrid, SCHWARTZ,  DORF,  BENACERRAF,  AND  PAUL  903 
which is a cross between an a+fl  + responder and an a-B- nonresponder, demon- 
strated that both the a + and fl+ alleles are fully dominant (6). 
The  major  conclusion  from  our  experiments  is  that  T  lymphocytes  from 
immunized mice possessing a responder allele at only one of the two Ir-GLib loci 
fail  to  proliferate  in  response  to  stimulation  with  GLcP. In  accord  with  this 
finding,  Katz et al.  (7),  in a  companion study, demonstrate that T-lymphocyte 
helper activity for DNP-FGG-primed B lymphocytes from (B6 ×  A)F1 respond- 
ers fails to develop in a+fl  -  or a-B  + parental donors primed with GL¢. Thus, in 
two systems which B lymphocytes appear to play no role, the expression of both 
Ir  genes  is  required  for  a  T-cell  response.  These  experiments  indicate  that 
neither the  a-gene nor the  /3-gene can be expressed exclusively in B  lympho- 
cytes. 
The proliferation data presented in this paper are compatible with the hypoth- 
esis that  both Ir  genes  are  expressed in  T  lymphocytes,  An  equally tenable 
hypothesis, however, is that one or both Ir genes are expressed in macrophages. 
Extensive studies in the guinea pig, using a similar T-lymphocyte proliferation 
assay, have indicated the requirement for antigen presentation by macrophages 
to  obtain  proliferation  (8).  In  addition,  it  was  shown  for Ir  gene-controlled 
systems, that T lymphocytes from (responder  x  nonresponder)F~ animals could 
only be activated by antigen-pulsed macrophages from the responder parent (9). 
One way to interpret these results is to ascribe to the macrophage the ability to 
exert  some  control  over the  specificity of the  immune  response  through  the 
function of It genes. 
The  results  in  this  paper  appear  to  be  at  odds  with  the  two-gene  model 
proposed by Munro  and  Taussig (3) based on their  interpretation  of the data 
obtained  with  (T,G)-A--L.  In  their  system  one  Ir  gene  is  postulated  to  be 
expressed in T  lymphocytes and the other in B  lymphocytes. The evidence for 
this hypothesis is that some nonresponder strains are defective in the production 
of an  antigen-specific,  T-cell  helper  factor,  while  other  nonresponder  strains 
synthesize this factor but lack B lymphocytes capable of binding the factor (3). 
The  apparent  discrepancy  is  emphasized  by the  observation  that  the  nonre- 
sponder strains  which make the T-cell factor (e.g., H-2k),  nonetheless,  fail to 
mount a  measurable  T-lymphocyte proliferative response to  (T,  G)-A--L. This 
was shown by us for the A/WySn, B10.A/SgSn, AKR/J, C3H/HeN, and B10.BR/ 
SgSn strains 2 and by Lonai and McDevitt for the C3H/DiSn strain  (10). The re- 
sults with GL¢ potentially demonstrate the same point,  although  no analysis 
for production of T-cell helper factor in either type of GL¢ nonresponder strain 
has as yet been carried out. 
There are several possible ways of reconciling this apparent discrepancy. One 
is to postulate that the T-lymphocyte proliferation response requires the action 
of both Ir genes, whereas, the production of the T-cell factor requires the action 
of only one of the two genes. For example, one might propose that both Ir genes 
are expressed in a single cell and that one controls differentiation events while 
the  other  controls  subsequent  proliferative  events.  Thus,  factor  production 
might  require  only the  onset  of differentiation,  whereas  proliferation  would 
require, in addition, the expression of the other Ir gene. Alternatively, it might 
be postulated that the T-lymphocyte proliferation assay requires the function of 904  T-LYMPHOCYTE RESPONSE TO  POLY-(GLU53LYS36pHEI]) 
two  distinct  cell  types,  and  that  only one ofthelr genes  is  expressed in  each  type 
of  cell.  For example, if  the interaction  of  two subclasses  of  T lymphocytes was 
necessary  for  the  proliferative  response to  antigens such  as  GL¢ and (T,G)-A--L, 
a  phenotypic nonresponder could  exist  which possessed  a T-ceU subset  capable of 
producing the helper factor.  Another variation  on this  two-cell  model would be 
to place the expression of  one of  the Ir genes in the macrophage. To make the 
data of Munro and Taussig consonant with thesis,  it would be necessary to 
further  postulate  that  the  Ir gene expressed in macrophages was also  expressed 
in B lymphocytes, so  that animals lacking the B-ceU  Ir gene could still  produce 
T-cell helper factor  by utilizing  the Ir gene expressed only in T lymphocytes. 
One would also  have a postulate that "responder" macrophages were not re- 
quired for  the priming of  factor-producing  T lymphocytes nor for  the production 
of  factor  on secondary antigenic  stimulation. 
Summary 
The antibody response to poly-(Glu~SLys38Phe  11)  (GLdP)  has been shown to be 
under the control  of  two independent, major histocompatibility-linked  immune 
response genes, designated a and ~. In the present work we demonstrate that 
the T-lymphocyte proliferative  response is also  under the control  of  these two 
immune response genes.  Thus, mice of  the  H-2  a,  H-2  b,  H-2  ~,  and  H-2'  haplotypes 
were all nonresponders to GLO. In contrast,  FI hybrids between these strains, 
such as (B10 × B10.A)FI and (C3H × SJL)F~,  as well  as several  recombinant 
mice derived from the nonresponder haplotypes, such as B10.A(5R), B10.HTT, 
and B10.S(9R), were all responders to GLO. The complementation between 
nonresponder genomes appeared to be stronger in the cis position  than in the 
trans position  for  some strain  combinations. The failure  of  strains  bearing only 
one of  the two responder alleles  to  show a  T-lymphocyte proliferative  response to 
GL&,  argues strongly that neither gene can be expressed exclusively in B 
lymphocytes. This conclusion  is  discussed  in  relation  to  another  two gene model 
which has recently  been proposed. 
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